Rheumatoid arthritis (RA) patients in Denmark with a history of solid tumor cancers, now in remission, faced no greater ...

Aclaris expects to begin the trial in the second quarter of the year. Credit: MacroEcon / Shutterstock. The US Food and Drug ...

The Trump administration launched such an offensive against science and American research that it's almost difficult to ...

Abatacept was not associated with an increased risk for malignancy in patients with rheumatoid arthritis or psoriatic arthritis based on clinical trial data, though observational data differed. Study ...

During his tenure at BMS, Dr. Banerjee served as the global lead for mid- to late-stage clinical development of Sotyktu (deucravacitinib), Orencia (abatacept) and clazakizumab (anti-IL-6 antibody) for ...

The earlier combined oral contraceptive use is initiated, the higher the risk for depression. HealthDay News — Use of hormonal contraceptives postpartum is associated with an increased risk for ...

Biological and targeted synthetic DMARDs were split into five classes: TNF inhibitors, interleukin (IL)-6 inhibitors, JAK inhibitors, rituximab (Rituxan, Genentech) and abatacept (Orencia ...

The following is a summary of “Cancer risk with tocilizumab/sarilumab, abatacept and rituximab treatment in patients with rheumatoid arthritis: a Danish cohort ...

Humira has possible interactions with alcohol, some other drugs, and certain supplements. Examples include TNF blockers, other biologics, and corticosteroids. Humira also interacts with vaccines ...

However, specific combinations such as abatacept with Janus kinase (JAK) inhibitors may be associated with increased risks. Researchers conducted an observational study using the health data ...

Background: Krebs von den Lungen 6 (KL-6) is a potential biomarker for determining the severity of interstitial lung disease (ILD) in patients with connective tissue disease (CTD). Whether KL-6 levels ...